118 related articles for article (PubMed ID: 4018914)
1. Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host.
Caignard A; Martin MS; Michel MF; Martin F
Int J Cancer; 1985 Aug; 36(2):273-9. PubMed ID: 4018914
[TBL] [Abstract][Full Text] [Related]
2. In vitro proliferative responses of spleen lymphocytes from rats bearing progressive or regressive tumors induced by cell variants of a syngeneic colon carcinoma.
Dearden-Badet MT; Pelletier H; Caignard A; Martin F
Int J Cancer; 1989 Feb; 43(2):334-9. PubMed ID: 2917805
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of lymphocytes infiltrating progressive and regressive tumor variants from a rat colonic cancer.
Pelletier H; Olsson NO; Lizard G; Martin F
Immunobiology; 1991 Mar; 182(2):188-96. PubMed ID: 1885206
[TBL] [Abstract][Full Text] [Related]
4. [Kinetic study of antitumor lymphocyte cytotoxicity in rats bearing progressive or regressive syngeneic colonic tumors].
Pelletier H; Olsson O; Lagadec P; Reisser D; Jeannin JF
C R Seances Soc Biol Fil; 1985; 179(5):669-78. PubMed ID: 2938696
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro reactivity of rat spleen cells against regressor and progressor colon-cancer cell variants.
Reisser D; Olsson NO; Martin F
Int J Cancer; 1993 Feb; 53(4):651-6. PubMed ID: 8436439
[TBL] [Abstract][Full Text] [Related]
6. Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors.
Martin F; Caignard A; Jeannin JF; Leclerc A; Martin M
Int J Cancer; 1983 Nov; 32(5):623-7. PubMed ID: 6358055
[TBL] [Abstract][Full Text] [Related]
7. Effects of a single injection of anti-asialo GM1 serum on natural cytotoxicity and the growth of a regressive colonic tumor in syngeneic rats.
Shimizu T; Pelletier H; Hammann A; Olsson NO; Martin MS; Martin F
Int J Cancer; 1987 Nov; 40(5):676-80. PubMed ID: 3316050
[TBL] [Abstract][Full Text] [Related]
8. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
Giovarelli M; Santoni A; Forni G
J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
[TBL] [Abstract][Full Text] [Related]
9. Effects of cyclosporin A on progressive and regressive tumors induced by two cancer lines derived from a single colon carcinoma chemically induced in the rat.
Shimizu T; Martin MS; Pelletier H; Lagadec P; Martin F
Immunobiology; 1989 Feb; 178(4-5):401-15. PubMed ID: 2785485
[TBL] [Abstract][Full Text] [Related]
10. Specificity of the immune response leading to protection or enhancement by regressive and progressive variants of a rat colon carcinoma.
Caignard A; Pelletier H; Martin F
Int J Cancer; 1988 Dec; 42(6):883-6. PubMed ID: 3263952
[TBL] [Abstract][Full Text] [Related]
11. Interleukin generation in experimental colon cancer of rats: effects of tumor growth and tumor therapy.
Ravikumar T; Rodrick M; Steele G; Marrazo J; O'Dwyer P; Dodson T; King V
J Natl Cancer Inst; 1985 Apr; 74(4):893-8. PubMed ID: 3872959
[TBL] [Abstract][Full Text] [Related]
12. Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cells.
Bonnotte B; Gough M; Phan V; Ahmed A; Chong H; Martin F; Vile RG
Cancer Res; 2003 May; 63(9):2145-9. PubMed ID: 12727832
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a rat protein (p 105) auto-antigenic in rats bearing a progressive syngeneic colon carcinoma.
Blottière HM; Menoret A; Burg C; Douillard JY; Le Pendu J
Int J Cancer; 1992 Jan; 50(2):315-20. PubMed ID: 1730526
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones.
Garrido C; Fromentin A; Bonnotte B; Favre N; Moutet M; Arrigo AP; Mehlen P; Solary E
Cancer Res; 1998 Dec; 58(23):5495-9. PubMed ID: 9850085
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors.
Bonnotte B; Favre N; Moutet M; Fromentin A; Solary E; Martin M; Martin F
J Immunol; 1998 Aug; 161(3):1433-8. PubMed ID: 9686608
[TBL] [Abstract][Full Text] [Related]
16. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M
Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360
[TBL] [Abstract][Full Text] [Related]
17. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
Fortner GW; Kuperman O; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
[TBL] [Abstract][Full Text] [Related]
18. Transplacental effect of a 15% olive-oil diet on functional activity of immune components in the spleen and colon tumors of rat offspring.
Kossoy G; Madar Z; Ben-Hur H; Gal R; Stark A; Cohen O; Zusman I
Oncol Rep; 2001; 8(5):1045-9. PubMed ID: 11496314
[TBL] [Abstract][Full Text] [Related]
19. Histoimmunological characterization of the cellular reaction to liver metastases induced by colon cancer cells in syngeneic rats.
Martin M; Chauffert B; Caignard A; Pelletier H; Hammann A; Martin F
Invasion Metastasis; 1989; 9(4):216-30. PubMed ID: 2786861
[TBL] [Abstract][Full Text] [Related]
20. Influence of the injection site on the tumorigenicity of a cloned colon tumor cell line in the rat.
Reisser D; Fady C; Lagadec P; Martin F
Bull Cancer; 1991; 78(3):249-52. PubMed ID: 2054523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
